34 results
8-K
EX-1.1
TRML
Tourmaline Bio Inc
26 Jan 24
Other Events
4:12pm
(i) a natural person’s name, street address, telephone number, e-mail address, photograph, social security number or tax identification number
8-K
EX-99.1
TRML
Tourmaline Bio Inc
24 Jan 24
Results of Operations and Financial Condition
5:10pm
grant programs may be subject to the anti-fraud and abuse provisions of the Social Security Act, the false claims laws, the privacy and security
8-K
EX-10.7
5h7ccvxpa6qbdmmusw7g
19 Oct 23
Tourmaline Bio Announces Closing of Merger with Talaris Therapeutics and Concurrent Private Placement of $75 Million
9:11pm
8-K
EX-10.10
ymlp6j4p1 t7s
19 Oct 23
Tourmaline Bio Announces Closing of Merger with Talaris Therapeutics and Concurrent Private Placement of $75 Million
9:11pm
424B3
n5ot8t8 1frjxqrvygz
15 Sep 23
Prospectus supplement
6:31am
S-4/A
b0iahg43dekkuo 139h
25 Aug 23
Registration of securities issued in business combination transactions (amended)
4:34pm
S-4
6e6omqegycf1rle
19 Jul 23
Registration of securities issued in business combination transactions
7:57pm
S-4
EX-10.15
1si9uljjk6d
19 Jul 23
Registration of securities issued in business combination transactions
7:57pm
425
92z ieajo9wgtab01tr
22 Jun 23
Business combination disclosure
9:12am
8-K
EX-2.1
s3k59uk90 oo8cd
22 Jun 23
Talaris Therapeutics and Tourmaline Bio Announce Merger Agreement
9:10am